Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 1-year average of 37.77%, near the low end of its 1-year range (0.00%–97.20%).
100.00% below its 12-month average of 37.77%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 97.20%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
37.77%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
52.24%
GROSS MARGIN AVG 15Y
62.43%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.44%
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$1.35B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.40B
Gross Margin
-91.00%
TTM Avg
-566.75%
3Y Avg
-1506.60%
5Y Avg
-994.02%
Market Cap
$1.41B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.42B
Gross Margin
14.79%
TTM Avg
13.21%
3Y Avg
12.77%
5Y Avg
12.70%
Market Cap
$1.43B
Gross Margin
98.97%
TTM Avg
9.74%
3Y Avg
-353.69%
5Y Avg
-246.22%
Market Cap
$1.44B
Gross Margin
83.12%
TTM Avg
85.05%
3Y Avg
87.98%
5Y Avg
90.85%
Market Cap
$1.45B
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
25.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omeros Corporation (OMER) | $1.35B | 0.00% | 37.77% | 0.00% | 0.00% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.35B | 0.00% | 0.00% | 0.00% | 0.00% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | 0.00% | 0.00% | 0.00% | 0.00% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -91.00% | -566.75% | -1506.60% | -994.02% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | 0.00% | 0.00% | 0.00% | 0.00% |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 14.79% | 13.21% | 12.77% | 12.70% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 98.97% | 9.74% | -353.69% | -246.22% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | 83.12% | 85.05% | 87.98% | 90.85% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | 0.00% | 50.00% | 25.00% | 25.00% |
| Kardigan, Inc. (KARD)vs › | $1.25B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 97.20% |
| 2026-03-31 | 91.65% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 98.83% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 99.18% |
| 2020-09-30 | 98.46% |
| 2020-06-30 | 98.91% |
| 2020-03-31 | 98.87% |
| 2019-12-31 | 98.80% |
| 2019-09-30 | 99.07% |
| 2019-06-30 | 99.79% |
| 2019-03-31 | 99.40% |
| 2018-12-31 | 99.29% |
| 2018-09-30 | 99.22% |
| 2018-06-30 | 92.99% |
| 2018-03-31 | 87.22% |
| 2017-12-31 | 96.61% |
| 2017-09-30 | 99.15% |
| 2017-06-30 | 99.08% |
| 2017-03-31 | 97.79% |
| 2016-12-31 | 97.06% |
| 2016-09-30 | 96.65% |
| 2016-06-30 | 96.73% |
| 2016-03-31 | 95.59% |
| 2015-12-31 | 93.75% |
| 2015-09-30 | 92.39% |
| 2015-06-30 | 88.55% |
| 2015-03-31 | 97.16% |
| 2014-12-31 | -2797.22% |
| 2014-09-30 | -3007.94% |
| 2014-06-30 | -27471.11% |
| 2014-03-31 | -11917.00% |
| 2013-12-31 | -2923.67% |
| 2013-09-30 | -2239.29% |
| 2013-06-30 | -3823.57% |
| 2013-03-31 | -186.58% |
| 2012-12-31 | 99.69% |
| 2012-09-30 | 99.67% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
